ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R
ScripThe Japanese government has started a new funding project for pharma bioventures in the country with a new JPY50bn ($420m) budget, aiming to strengthen the domestic ecosystem for drug and vaccine deve